Moors & Cabot, Inc. Nu Cana PLC Transaction History

Moors & Cabot, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Dec 08, 2021	BUY	$1.95 - $2.85 $35,082 - $51,274	17,991 Added 256.68%	25,000 $65,000
Q3 2021 Nov 05, 2021	BUY	$1.95 - $2.85 $13,667 - $19,975	7,009 New	7,009 $245,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $47.5M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.